Although CSF progranulin may be elevated during the progress of Alzheimer’s disease and may add to its risk, further investigations are warranted to examine its potential for assessing disease severity and early detection. The gene discussed is GRN; the disease is early-onset autosomal dominant Alzheimer disease.